Want a deeper scan?
Get a guided tour of your organization’s security posture from an UpGuard team member.


This is a preliminary report on Celgene’s security posture. If you want in-depth, always up-to-date reports on Celgene and millions of other companies, start a free trial today. UpGuard is the new standard in third-party risk management and attack surface management. Our security ratings engine monitors billions of data points each day.
Get the full report

UpGuard Security Rating

/ 950
This is a 0-950 security rating for Celgene. The higher the rating, the more likely Celgene has good security practices. For complete visibility of the security posture of Celgene, start a free trial of UpGuard.

Company info

Summit, NJ, United States.
Mark J. Alles
Last updated
Last updated
Last updated today

Security report for Celgene

Celgene Corporation is an American biotechnology company that discovers, develops and commercializes medicines for cancer and inflammatory disorders. It is incorporated in Delaware and headquartered in Summit, New Jersey. The company's major product is Revlimid (lenalidomide), in combination with dexamethasone for the treatment of multiple myeloma patients.
Get the full report
Last updated today

Celgene Data Breaches and Security News

Relevant news, breaches and security articles relating to Celgene.

More security reports

Compare Celgene's security performance with other companies.

Leader in Third Party & Supplier Risk Management Software

See how UpGuard shapes up against other platforms in the market.
Free instant security score

How secure is your organization?

Request a free cybersecurity report to discover key risks on your website, email, network, and brand.
  • Check icon
    Instant insights you can act on immediately
  • Check icon
    Hundreds of risk factors including email security, SSL, DNS health, open ports and common vulnerabilities
Website Security scan resultsWebsite Security scan rating
Want a full vendor security report for this company?
Start your free trial and unlock real-time insights to identify and assess vendor risks.